FDA Drug Approvals
Printable Version   Email to a friend

Cardizem LA Biovail Laboratories Incorporated - Treatment for Hypertension

Cardizem LA is a graded extended-release formulation of diltiazem HCl providing 24-hour blood pressure control with a single daily dose. Cardizem LA is used for the treatment of high blood pressure or hypertension.

Related Articles:

FDA Approves Biovail's Cardizem LA for the Treatment of Angina. - April 5, 2004

Latest FDA Drug Approvals...

FDA Drug Approvals Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

More News Resources


MedNotes
Advertisement